产品详情
In vitro (25°C) | DMSO | 19 mg/mL (79.73 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (8.39 mM) | ||
In vivo | 5% DMSO+40%PEG 300+ 5% Tween80 + ddH2O | 0.4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 41.97 mL | 209.84 mL | 419.67 mL |
0.5 mM | 8.39 mL | 41.97 mL | 83.93 mL |
1 mM | 4.2 mL | 20.98 mL | 41.97 mL |
5 mM | 0.84 mL | 4.2 mL | 8.39 mL |
*The above data is based on the productmolecular weight 238.28. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A12437 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 238.28 |
Formula | C15H14N2O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 204005-46-9 |
Synonyms | SU-5416, SU5416 |
SMILES | CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C |
产品标签
Product Questions
Product Questions
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
CYC116 (CYC-116)
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
TPT-260 (Dihydrochloride)
TPT-260是噻吩硫脲衍生物。
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
(-)-Catechin gallate
(-)-Catechin gallate是绿茶的抗氧化成分。在uM浓度下,抑制VEGF诱导的酪氨酸磷酸化。
Motesanib Diphosphate (AMG-706)
Motesanib也称为AMG-706,是一种有效的ATP竞争性的VEGFR1/2/3抑制剂,IC50分别为2 nM/3 nM/6 nM;对Kit具有相似的抑制…